The Research

This systematic review and meta-analysis assessed the effectiveness of various combination therapies compared to monotherapies in treating allergic rhinitis (AR). The study analyzed data from 53 randomized controlled trials, focusing on combinations such as antihistamines (ATH) with decongestants, leukotriene receptor antagonists (LTRA), or saline irrigation, and intranasal corticosteroids (INCS) combined with intranasal antihistamines, LTRA, decongestants, or saline irrigation. 

This study evaluated a novel triple spray composed of triamcinolone (a corticosteroid), azelastine (an antihistamine), and oxymetazoline (a decongestant) delivered in a single formulation. The goal was to determine whether this combination offered superior symptom relief for allergic rhinitis (AR) compared to the use of a single-agent nasal spray.